Cargando…
Development and Validation of an HPLC Method for Determination of Antidiabetic Drug Alogliptin Benzoate in Bulk and Tablets
Alogliptin benzoate, a member of dipeptidyl peptidase-4 inhibitors, is a recent drug developed by Takeda Pharmaceutical Company for the treatment of Type 2 diabetes; it potentiates the effect of incretin hormones through the inhibition of their degradation. Alogliptin can be used alone or in combina...
Autores principales: | Naseef, Hani, Moqadi, Ramzi, Qurt, Moammal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174800/ https://www.ncbi.nlm.nih.gov/pubmed/30345140 http://dx.doi.org/10.1155/2018/1902510 |
Ejemplares similares
-
Preparation and Evaluation of Vitamin D3 Supplementation as Transdermal Film-Forming Solution
por: Kittaneh, Majd, et al.
Publicado: (2022) -
The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets
por: Ma’ali, Anwar, et al.
Publicado: (2023) -
Salting-out induced liquid–liquid microextraction for alogliptin benzoate determination in human plasma by HPLC/UV
por: Hammad, Sherin F., et al.
Publicado: (2021) -
Development and Validation of HPTLC Method for the Estimation of Rizatriptan Benzoate in Bulk and Tablets
por: Sundar, B. Syama, et al.
Publicado: (2010) -
Alogliptin benzoate for management of type 2 diabetes
por: Saisho, Yoshifumi
Publicado: (2015)